CN Stock MarketDetailed Quotes

603566 Pulike Biological Engineering,Inc.

Watchlist
  • 14.04
  • +0.50+3.69%
Market Closed May 15 15:00 CST
4.86BMarket Cap41.05P/E (TTM)

About Pulike Biological Engineering,Inc. Company

The company is a high-tech enterprise whose main business is R&D, production and operation of veterinary biological products and pharmaceuticals. Its innovative ability and comprehensive strength are at the forefront of the industry. It adheres to the purpose of “gold medal quality, benefits humanity”, adheres to the development concept of “innovation achieves the future”, adheres to the business strategy of “decent and steady management”, and engages in research, production and promotion of new veterinary vaccines and new veterinary drugs from a high starting point and high standards, and is committed to building a world-class brand in China's animal insurance industry. The company is mainly engaged in R&D, production and sales of veterinary biological products, chemicals and Chinese veterinary medicines. The company's main products are vaccines and pharmaceuticals for pigs, vaccines and pharmaceuticals for poultry, vaccines and pharmaceuticals for ruminants, and vaccines and pharmaceuticals for pets. Corporate honors: It was later certified as “Key High-tech Enterprise of the National Torch Program”, “National Technological Innovation Demonstration Enterprise”, and “Leading Innovation Enterprise in Henan Province”.

Company Profile

Short Name-A普莱柯
Symbol-A603566
Company NamePulike Biological Engineering,Inc.
Listing DateMay 18, 2015
Issue Price15.52
Shares Offered40.00M share(s)
FoundedJun 22, 2002
Listed ExchangeSH Stock Exchange
Legal Representativewei hu
General Managerwei hu
Secretaryrui zhao
Accounting FirmLixin Certified Public Accountants (Special General Partnership)
Securities Representativexiaolong tian
Legal CounselBeijing Deheng Law Firm
Employees820
Phone0379-63282386
Office AddressNo. 15 Zhenghe Road, Luolong District, Luoyang City, Henan Province
Zip Code471000
Registered AddressLingbo Road, High-tech Development Zone, Luoyang Area, China (Henan) Pilot Free Trade Zone
Fax0379-63282386
Emailir@pulike.com.cn
Business License410392100006212
BusinessProduction, sale and operation of veterinary vaccines, egg yolk antibodies and veterinary chemicals, traditional Chinese medicines, disinfectants, and veterinary drugs (the specific scope and validity period are subject to the license issued by the relevant departments); veterinary drug product development and technology transfer, related technical consulting and services; technology and goods import and export business (except where prohibited by national laws and regulations). (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

  • Name
  • Position
  • Salary
  • xuke zhang
  • Chairman, Directors, Nomination Committee Members, Chairman of the Strategy Committee, Member of the Remuneration and Assessment Committee
  • 1.16M
  • dechao qin
  • Vice Chairman, Directors, Strategy Committee Member, Audit Committee Member
  • 2.50M
  • yongjun song
  • Directors, Deputy General Manager, Strategy Committee Member
  • 1.16M
  • wei hu
  • Directors, General Manager, Strategy Committee Member
  • 2.62M
  • lianfeng pei
  • Directors, Chief Financial Officer
  • 1.06M
  • rui zhao
  • Directors, Board Secretary
  • 887.80K
  • xiansheng zhang
  • Independent Directors, Nomination Committee Members, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
  • 96.00K
  • yongzhang cao
  • Independent Directors, Chairman of the Remuneration and Assessment Committee, Strategy Committee Member
  • 96.00K
  • chuduan wang
  • Independent Directors, Audit Committee Member, Chairman of the Nomination Committee
  • 96.00K
  • xiaolong tian
  • Securities Affairs Representative
  • 198.20K
  • lipeng zhou
  • Chairman of the Supervisory Board, Auditors
  • 1.05M
  • xiaoli wang
  • Auditors
  • 172.80K
  • kegong tian
  • Deputy General Manager
  • 4.82M
  • bing han
  • Deputy General Manager
  • 815.50K
  • dongjuan yuan
  • Employee Supervisors
  • 150.50K

Market Insights

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More